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Objectives: Arteriogenic erectile dysfunction (ED) is a target organ disease of atherosclerosis, 
and therefore might be a predictor of systemic atherosclerosis. Being systemic, it might be 
  possible to evaluate the extent of atherosclerosis from retinal vascular findings. We investigated 
the possible correlation between penile cavernosal artery blood flow and retinal vascular   findings 
in patients with arteriogenic ED.
Patients and methods: Sixty patients with ED were divided according to the peak systolic 
velocity (PSV) in their penile cavernosal arteries into two groups; Group A included 30 patients 
with PSV less than 25 cm/sec, and Group B included 30 patients with PSV more than 35 cm/sec. 
Blood flow in the penile cavernosal artery was measured with color Doppler ultrasonography. 
All patients were assessed by ocular fundus examination under amydriatic conditions to evaluate 
retinal vascular atherosclerotic changes using Hyman’s classification.
Results: Evidence of retinal vascular atherosclerotic changes was found in 19 patients (63.3%) 
in Group A and in 10 patients (33.3%) in Group B.
Conclusions: Our study confirms the possibility of predicting penile arterial vascular status 
in patients with ED from their retinal vascular findings by using amydriatic simple, practical 
funduscopy.
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Introduction
Erectile dysfunction (ED) is a prevalent condition that affects more than 150 million 
men worldwide, and is predicted to double within the next 20 years.1 Although ED 
was previously considered to be primarily psychogenic, recent research elucidating the 
physiology of penile erection, as well as the pathogenesis of ED shows accumulating 
evidence that ED should be considered as a vascular disorder.2
Atherosclerosis and ED not only share common risk factors, including dyslipidemia 
and cigarette smoking, but also show obvious coassociation with various   cardiovascular 
and systemic vascular diseases, including coronary artery disease, hypertension, 
  diabetes mellitus (DM), and peripheral and cerebrovascular diseases.3–5 Additionally, 
arteriogenic ED is identified as a marker for silent vascular disease and a predictor of 
systemic atherosclerosis.6–11
Atherosclerosis is a systemic disorder that uniformly affects the vascular system, 
even though clinical manifestations rarely appear simultaneously in different vascular 
beds in the same patient due to the different sizes of the arteries supplying different 
organs. In addition, endothelial dysfunction is associated with impaired release and 
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Retinal blood vessels are one of the most superficial 
branches of the vascular tree, and pathological changes in 
these vessels can be easily seen and recorded by   funduscopy, 
which affords a unique opportunity for   noninvasive   assessment 
of the systemic microcirculation in large populations.14–16 
Retinal microvascular abnormalities, such as retinal   arteriolar 
  narrowing and retinopathy, have been associated with 
  systemic   vascular disorders, including   hypertension, meta-
bolic   syndrome, Type 2 DM, and cardiovascular diseases, 
suggesting it is a marker of atherosclerosis.17–20
Ocular funduscopy allows direct visualization of the 
retinal vasculature, and accordingly can be used  routinely 
as a diagnostic tool for atherosclerosis, not only by 
  ophthalmologists but also by primary care physicians.21
We investigated the possible correlation between penile 
cavernosal artery blood flow and retinal vascular findings in 
patients with arteriogenic ED.
Patients and methods
The research followed the tenets of the Declaration of 
Helsinki, and informed consent was obtained from patients 
to whom all details of the procedure were explained, with 
emphasis on the intended outcome. The research was 
approved by our institutional review board.
The study included 60 patients with ED recruited from 
the Andrology and Sexology Outpatient Clinic of the Cairo 
University Hospital. ED was defined as an inability to achieve 
or maintain an erection adequate for sexual intercourse for 
at least six months.22 All patients completed the validated 
Arabic translation of the International Index of Erectile 
  Function (IIEF-5) questionnaire.23 ED was diagnosed in 
patients having an IIEF-5 score of ,21.24
Exclusion criteria included diminished sexual desire, 
hypogonadism, hyperprolactinemia, Peyronie’s disease, ED 
due to anatomical penile deformities, previous spinal cord 
injury, previous radical prostatectomy, any substance abuse 
disorders, a psychiatric history with or without medications, 
and DM (to avoid diabetes-specific retinopathies confound-
ing our findings).
A medical, surgical, and psychosexual history was taken 
from all patients, and a detailed physical examination was 
performed. All patients were given an intracavernous injec-
tion of 20 µg prostaglandin E1, and were then evaluated by 
penile dynamic duplex study using color ultrasound with a 
7.5 mHz linear array transducer having a color flow-mapping 
capability (Esaote Biomedical AU3, Italy).
The peak systolic velocity (PSV) of the penile   cavernosal 
arteries was used to classify patients into two groups, 
ie, Group A which included 30 patients with PSV less than 
25 cm/sec, and Group B which included 30 patients with 
PSV more than 35 cm/sec.
The same ophthalmologist carried out the fundus exami-
nation in all 60 patients to avoid interobserver variability. In 
addition, the ophthalmologist was masked as to the nature 
of the patient’s andrological condition. Fundus examination 
was carried out using a 90 diopter indirect ophthalmoscopy 
lens, in conjunction with the slit lamp. This provided strong 
illumination, magnification, and stereoscopic view. Dila-
tion with 1% tropicamide was only performed when media 
opacity or lack of patient cooperation prevented thorough 
and proper fundus examination. Fundus photography was 
only performed to document the findings in some cases, 
and was not used routinely. Evaluation of retinal vascular 
atherosclerotic changes was listed according to Hyman’s 
classification.25
Descriptive statistics (mean and standard deviation) were 
used for summarizing quantitative data, while percentages 
were used for qualitative data. Statistical analysis was per-
formed using the chi-square test and the independent t-test. 
The 95% confidence interval (CI) was calculated. Signifi-
cance was set to P , 0.05. All statistical calculations were 
done using computer program SPSS (Statistical Package for 
the Social Science: SPSS Inc, Chicago, IL).
Results
The present study was carried out in 60 ED patients who 
were further divided into two groups according to their 
PSV   determined by penile duplex study. Group A included 
30 patients diagnosed as having arteriogenic ED (PSV less 
than 25 cm/sec), and Group B included 30 patients diagnosed 
as having nonarteriogenic ED (PSV more than 35 cm/sec).
The age (mean + SD) of Group A patients was 50.83 ± 8.98 
years, and for Group B patients was 46.07 ± 11.11 years. There 
was no statistical difference in age between the groups.
The clinical characteristics, hemodynamic values, and fun-
duscopic findings for both groups are shown in the Table 1.
On analyzing our data, highly significant differences were 
found in both groups for right and left PSV and IIEF-5 scores. 
The same differences for right and left PSV and IIEF-5 scores 
were found between smokers and nonsmokers, and between 
hypertensive and normotensive subjects.
Funduscopic findings showed that 32 ED patients had 
normal retinal vasculature, while 29 had abnormal retinal 
vascular findings (27 Grade I and two Grade II). Abnormal 
retinal vascular findings were detected in 63.3% (19/30) 
of patients with arteriogenic ED (Group A), while only Clinical Ophthalmology 2010:4
Table 1 Data of the studied groups (mean ± sD, range)
Total IIEF-5 Right PSV  
(cm/sec)
Left PSV  
(cm/sec)
Right EDV  
(cm/sec)
Left EDV 
(cm/sec)
group A (n = 60) 6.7 ± 1.82  
(3–11)
19.1 ± 3.39 
(12.0–24.0)
18.57 ± 3.88 
(12.0–24.0)
8.43 ± 5.1 
(1–24)
8.87 ± 5.55 
(1.0–29.0)
group B (n = 40) 10.73 ± 2.84*  
(6.0–18.0)
48.57 ± 10.98*  
(36.0–76.0)
49.83 ± 11.37*  
(36.0–76.0)
3.77 ± 1.83*  
(1.0–7.0)
3.3 ± 2.1* 
(1.0–8.0)
Hypertensives
group A (n = 22) 6.36 ± 1.03 17.36 ± 1.29 15.82 ± 2.44 3.18 ± 1.78 2.18 ± 1.6
group B (n = 8) 10.83 ± 4.31* 38.67 ± 2.16* 42.67 ± 6.53* 5.67 ± 1.2* 7.0 ± 2.37*
Normotensives
group A (n = 38) 6.89 ± 2.16 20.1 ± 3.83 20.16 ± 3.7 9.13 ± 5.4 9.33 ± 6.04
group B (n = 23) 10.71 ± 2.48* 51.04 ± 10.9* 38.67 ± 11.7* 4.11 ± 1.82* 3.95 ± 2.1*
Smokers
group A (n = 28) 6.86 ± 2.14 18.43 ± 2.56 17.64 ± 3.48 7.27 ± 3.07 7.82 ± 3.06
group B (n = 14) 10.91 ± 2.17* 45.45 ± 8.12* 47.64 ± 10.72* 3.29 ± 1.98* 2.64 ± 2.2*
Nonsmokers
group A (n = 23) 6.56 ± 2.1 19.69 ± 3.2 19.38 ± 2.8 9.1 ± 5.9 9.47 ± 6.59
group B (n = 26) 10.63 ± 3.22* 50.37 ± 12.2* 51.1 ± 11.8* 4.19 ± 1.1* 3.88 ± 1.4*
Funduscopy
group A
normal (n = 22) 6.55 ± 2.02 22.73 ± 1.42 22.82 ± 1.33 4.0 ± 2.0 4.1 ± 2.1
Affected (n = 38) 6.79 ± 1.75* 17.0 ± 2.2* 16.1 ± 2.42* 3.63 ± 1.74* 2.8 ± 2.0*
group B
normal (n = 28) 
Affected (n = 12)
11.2 ± 3.13 
9.80 ± 1.93*
53.6 ± 10.1 
38.5 ± 1.84*
54.8 ± 10.8 
39.9 ± 2.4*
5.55 ± 1.6* 
9.9 ± 5.6*
6.0 ± 1.9* 
10.3 ± 6.2*
Abbreviations: iiEF-5, score of the international index of erectile function questionnaire; PsV, peak systolic velocity; EDV, end diastolic velocity.
*Statistically significant.
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33.3% (10/30) of Group B patients showed retinal vascular 
  abnormalities on funduscopic examination.
Among ED patients with normal retinal findings, the 
mean (SD) right and left PSV and IIEF-5 scores were 22.73 
(1.42), 22.82 (1.33), and 6.55 (2.02) for Group A, and 53.6 
(10.11), 54.8 (10.8), and 11.2 (3.14) for Group B patients, 
respectively. However, in ED patients with abnormal retinal 
findings, the mean (SD) right and left PSV and IIEF-5 scores 
were 17 (2.16), 17.11 (2.42), and 6.79 (1.75) for Group A, 
and 38.5 (1.84), 39.9 (2.42), and 9.8 (1.93) for Group B 
patients, respectively. Furthermore, a highly significant dif-
ference was detected in patients with normal and abnormal 
retinal findings within the same group for right and left PSV 
and IIEF-5 scores.
Discussion
ED is increasingly recognized as a neurovascular phenomenon 
which is particularly vulnerable to circulatory disturbances. 
Recent research provides accumulating evidence of the role 
of ED as a common precursor of systemic atherosclerosis,26 
as well as highlighting its role in predicting cardiac and sys-
temic vascular disorders.5–9,11 Atherosclerosis is a systemic 
disorder, however its clinical manifestations show an ordered 
progression, and recognition of atherosclerotic changes in 
one organ can predict the next organ likely to be affected.26 
The retina provides a window of opportunity to study the 
human circulation. Retinal arterioles can be visualized easily 
and noninvasively, and have anatomical and physiological 
characteristics similar to those of the cerebral and coronary 
microcirculations, to the extent that the recognition of hyper-
tensive retinopathy plays an important role in cardiovascular 
risk stratification of hypertensive patients.25
In the present study, abnormal retinal vascular findings 
were detected in 63.3% of arteriogenic ED patients, which 
is a significantly higher prevalence than the 33.3% of ED 
patients with normal penile cavernosal arterial blood flow. 
This suggests that the penile vascular bed represents a target 
organ for atherosclerosis, adding to the evidence of the close 
relationship between ED and systemic vascular diseases. 
Similarly, the retinal microvascular circulation represents 
another target for atherosclerotic abnormalities, including 
retinal arteriolar narrowing and retinopathy, which shows an 
association with many systemic vascular disorders, including 
hypertension, DM, and cardiovascular disease.17–20 In our 
study, the mean right and left PSV and IIEF-5 scores were 
significantly lower in arteriogenic ED patients with retinal 
involvement than those of the nonarteriogenic ED group 
(P , 0.01).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Smoking is one of the main risk factors implicated in 
the pathogenesis of both ED and systemic atherosclerotic 
vascular disease.27 In our study, smokers represented 46.7% 
of arteriogenic ED patients compared with 36.7% of the 
nonarteriogenic group. In 2003, Kawanishi et al failed to 
find a significant effect of cigarette smoking on cavernosal 
or fundus artery findings, attributing this to the difficulty in 
measuring exposure to cigarette smoking.14 However, the 
right and left PSV and IIEF-5 scores of our patients were 
significantly different between smokers and nonsmokers 
(P , 0.01).
Similarly, our data revealed highly significant differences 
in right and left PSV and IIEF-5 scores between hypertensive 
and normotensive ED patients. This observation differs from 
that of Kawanishi et al who found that hypertension was not 
a significant factor for retinal findings or cavernosal arterial 
status, stating that all the hypertensive patients in their study 
had adequately controlled blood pressure.14
Although the various clinical classifications of   retinal 
  vascular findings remain controversial, funduscopic 
  assessment of retinal vascular abnormalities is still the only 
clinical tool that can detect arteriolar abnormalities.28,29 In 
spite of the existence of several classifications of   hypertensive 
retinopathy, their relevance to current clinical practice is 
still questionable. The major criticisms are that they do not 
enable the clinician to distinguish between low retinopathy 
grades and that these retinopathy grades failed to be closely 
correlated with the severity of hypertension.1,30–33 Hence 
we chose to use the Hyman’s classification which clearly 
distinguishes between retinal vascular abnormalities on the 
basis of localized constriction, arteriolar stenosis or nicking, 
hemorrhage, exudates, and disk edema.25
Although we totally agree with studies showing that 
signs of hypertensive retinopathy can be reliably identi-
fied with a standardized examination of photographs of 
the fundus, we believe that these systems might introduce 
errors of their own because they are highly sophisticated 
methods that rely on highly specialized and adequately 
trained ophthalmologists.34,35 However, even if such software 
becomes widely available, it is expensive and therefore puts 
a burden on struggling economies. Hence our decision was to 
rely on readily available ophthalmic equipment that is more 
economical and serves as a simple, practical,   acceptable, 
noninvasive screening tool for large populations, and can 
be used even by primary care physicians. Additionally, this 
method would be more economical in developing countries 
for investigating patients seeking medical advice for ED, 
where it would be unacceptable to involve them in expensive, 
time-consuming, and invasive investigations for screening 
purposes.
Our study suggests the possibility of correlating penile 
arterial vascular status in patients with ED with retinal 
v  ascular findings by using amydriatic funduscopy, which is 
a simple practical method.
Arteriogenic ED is a target organ disease of   atherosclerosis 
that adds to the evidence of a close relationship between ED 
and cardiovascular diseases.
Acknowledgment
This article was presented by Professor Shawky El-Haggar 
at The International Society of Sexual Medicine Congress 
held in September 2006 in Cairo, Egypt.
Disclosure
The authors have no financial interest as consultants, 
reviewers, shareholders, or evaluators in any of the products 
mentioned. No financial grants from public or private orga-
nizations were received.
References
  1.  Meuleman EJ. Prevalence of erectile dysfunction: Need for treatment? 
Int J Impot Res. 2002;14 Suppl 1:S22–S28.
  2.  Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med. 
2003;54:153–168.
  3.  Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erec-
tile dysfunction and its risk factors. Int J Androl. 1997;20:323–334.
  4.  Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. 
Impotence and its medical and psychosocial correlates: Results of the 
Massachussetts Male Aging Study. J Urol. 1994;151:54–61.
  5.  Roumeguere T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. 
Erectile dysfunction is associated with a high prevalence of hyperlipi-
demia and coronary heart disease risk. Eur Urol. 2003;44:355–359.
  6.  Burchardt M, Burchardt T, Anastasiadis AG, et al. Erectile dysfunction 
is a marker for cardiovascular complications and psychological function-
ing in men with hypertension. Int J Impot Res. 2001;13:276–281.
  7.  El-Sakka A, Morsy A, Fagih B. Enhanced external counterpulsation in 
patients with coronary artery disease-associated erectile dysfunction. 
Part I: Effects of risk factors. J Sex Med. 2007;4:771–779.
  8.  Heruti RJ, Uri I, Arbel Y, Swartzon M, Galor S, Justo D. Erectile 
  dysfunction severity might be associated with poor cardiovascular 
prognosis in diabetic men. J Sex Med. 2007;4:465–471.
  9.  Jackson G. Erectile dysfunction: A marker of silent coronary artery 
disease. Eur Heart J. 2006;27:2613–2614.
  10.  Kaya C, Uslu Z, Karaman I. Is endothelial function impaired in erectile 
dysfunction patients? Int J Impot Res. 2006;18:55–60.
  11.  Solomon H, Man JW, Jackson G. Erectile dysfunction and the 
  cardiovascular patient: Endothelial dysfunction is the common denomi-
nator. Heart. 2003;89:251–253.
  12.  Bocchio M, Desideri G, Scarpelli P, et al. Endothelial cell activation in 
men with erectile dysfunction without cardiovascular risk factors and 
overt vascular damage. J Urol. 2004;171:1601–1604.
  13.  Cheitlin MD. Erectile dysfunction: The earliest sign of generalized 
vascular disease? J Am Coll Cardiol. 2004;43:185–186.
  14.  Kawanishi Y, Kimura K, Nakanishi R, Numata A, Taguchi H. Retinal 
vascular findings and penile cavernosal artery blood flow. BJU Int. 2003; 
92:977–980.Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1051
Retinal vascular findings in erectile dysfunction
  15.  Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. 
Retinal microvascular abnormalities and their relationship with 
hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 
2001;46:59–80.
  16.  Wong TY, McIntosh R. Systemic associations of retinal microvascular 
signs: A review of recent population-based studies. Ophthalmic Physiol 
Opt. 2005;25:195–204.
  17.  Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortal-
ity, and retinal microvascular characteristics in Type 1 diabetes: Wis-
consin epidemiologic study of diabetic retinopathy. Arch Intern Med. 
2004;164:1917–1924.
  18.  van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident 
retinopathy in a diabetic and nondiabetic population: The Hoorn study. 
Arch Ophthalmol. 2003;121:245–251.
  19.  Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar diameter and 
risk for hypertension. Ann Intern Med. 2004;140:248–255.
  20.  Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective 
cohort study of retinal vessel diameters and risk of hypertension. BMJ. 
2004;329:79.
  21.  Snead MP, Rubinstein MP, Jacobs PM. The optics of fundus examina-
tion. Surv Ophthalmol. 1992;36:439–445.
  22.  Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802–1813.
  23.  Shamloul R, Ghanem H, Abou-zeid A. Validity of the Arabic version 
of the sexual health inventory for men among Egyptians. Int J Impot 
Res. 2004;16:452–455.
  24.  Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development 
and evaluation of an abridged, 5-item version of the International Index 
of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunc-
tion. Int J Impot Res. 1999;11:319–326.
  25.  Hyman BN. The eye as a target organ: An updated classification of hyper-
tensive retinopathy. J Clin Hypertens (Greenwich). 2000;2:194–197.
  26.  Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction 
the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 
2003;44:352–354.
  27.  Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN. 
  Isolated and borderline isolated systolic hypertension relative to 
  long-term risk and type of stroke: A 20-year follow-up of the National 
Health and Nutrition Survey. Stroke. 2002;33:271–278.
  28.  Pearson TA. New tools for coronary risk assessment: What are their 
advantages and limitations? Circulation. 2002;105:886–892.
  29.  Stanton AV , Mullaney P, Mee F, O’Brien ET, O’Malley K. A method 
of quantifying retinal microvascular alterations associated with blood 
pressure and age. J Hypertens. 1995;13:41–48.
  30.  Chatterjee S, Chattopadhyay S, Hope-Ross M, Lip PL. Hypertension and 
the eye: Changing perspectives. J Hum Hypertens. 2002;16:667–675.
  31.  Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hyper-
tensive retinopathy: A review of existing classification systems and a 
suggestion for a simplified grading system. J Hum Hypertens. 1996; 
10:93–98.
  32.  Fuchs FD, Maestri MK, Bredemeier M, et al. Study of the usefulness 
of optic fundi examination of patients with hypertension in a clinical 
setting. J Hum Hypertens. 1995;9:547–551.
  33.  Schubert HD. Ocular manifestations of systemic hypertension. Curr 
Opin Ophthalmol. 1998;9:69–72.
  34.  Couper DJ, Klein R, Hubbard LD, et al. Reliability of retinal pho-
tography in the assessment of retinal microvascular characteristics: 
The Atherosclerosis Risk in Communities Study. Am J Ophthalmol. 
2002;133:78–88.
  35.  Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive 
retinopathy revisited: Some answers, more questions. Br J Ophthalmol. 
2005;89:1646–1654.